Inovio Pharmaceuticals
INO
#8897
Rank
โ‚น12.77 B
Marketcap
โ‚น185.96
Share price
2.48%
Change (1 day)
-45.37%
Change (1 year)

Inovio Pharmaceuticals (INO) - Total debt

Total debt on the balance sheet as of September 2025 : โ‚น0.90 Billion

According to Inovio Pharmaceuticals's latest financial reports the company's total debt is โ‚น0.90 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Inovio Pharmaceuticals - Total debt on balance sheet (from 1998 to 2025)

Total debt by year

Year Total debt Change
2024-12-31โ‚น1.01 B-59.53%
2023-12-31โ‚น2.51 B-5.25%
2022-12-31โ‚น2.65 B7.98%
2021-12-31โ‚น2.45 B-13.93%
2020-12-31โ‚น2.85 B-59.75%
2019-12-31โ‚น7.09 B
2018-12-31N/A
2010-12-31N/A-100%
2009-12-31โ‚น0.56 B-3.42%
2008-12-31โ‚น0.58 B
2003-12-31โ‚น15.07 M1423.21%
2002-12-31โ‚น0.98 M-57.36%
2001-12-31โ‚น2.32 M
2001-03-31โ‚น5.47 M6.09%
2000-03-31โ‚น5.16 M21.65%
1999-03-31โ‚น4.24 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Pfizer
PFE
โ‚น5.466 T 607,153.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น4.114 T 456,926.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
โ‚น31.71 B 3,423.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น2.876 T 319,474.46%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
โ‚น3.716 T 412,805.93%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚น2.143 T 238,038.96%๐Ÿ‡ฌ๐Ÿ‡ง UK
Gilead Sciences
GILD
โ‚น2.240 T 248,807.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Cleveland BioLabs
CBLI
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA